Dr. Karen Talmadge
Dr. Karen Talmadge has been an award-winning volunteer leader for the American Diabetes Association since 1993. She is inspired by her 23-year-old daughter who has lived with type 1 diabetes for 21 years. She is currently 2013 Chair of the Board of the Association. She received her PhD from Harvard University in Cambridge, MA, and her A.B. from Bryn Mawr College, Bryn Mawr, PA. She is an entrepreneur and executive in the biomedical industry. She is currently President of Nabu Health Care Consulting, Chair of the Board of Directors of Gynesonics, and serves on the Boards of Directors of Amplyx Pharmaceuticals, Velocity Pharmaceutical Development and Venous Health Systems. She has a long history of executive and research positions in pharmaceutical and biotechnology companies. For example, she joined Medtronic Spinal and Biologics, Sunnyvale, CA., in 2007 when it acquired Kyphon Inc., a minimally-invasive spine company she co-founded and funded.
